Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VANDANA DALTON

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1508126889
CMS profile
462997
Location
FENTON, MO

General Payments · PY2019–2024

$929.80

  • Reported across 50 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$294.01

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $294.01 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Astellas Pharma US Inc $83.77 5
PFIZER INC. $82.35 4
Hologic Sales and Service, LLC $44.05 2
Sage Therapeutics, Inc. $39.95 2
Amgen Inc. $23.66 1
Organon LLC $20.23 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $77.63 5
PY2021 $82.90 5
PY2022 $214.77 12
PY2023 $260.49 13
PY2024 $294.01 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $23.66 11/07/2024 Food and Beverage Undisputed 01/23/2026 1115548887 CMS
Astellas Pharma US Inc $15.07 06/06/2024 Food and Beverage Undisputed 01/23/2026 1139354941 CMS
Astellas Pharma US Inc $17.43 07/22/2024 Food and Beverage Undisputed 01/23/2026 1139273422 CMS
Astellas Pharma US Inc $18.09 09/30/2024 Food and Beverage Undisputed 01/23/2026 1139406135 CMS
Astellas Pharma US Inc $19.97 10/30/2024 Food and Beverage Undisputed 01/23/2026 1139420587 CMS
Astellas Pharma US Inc $13.21 12/03/2024 Food and Beverage Undisputed 01/23/2026 1139435286 CMS
Hologic Sales and Service, LLC $23.84 04/09/2024 Food and Beverage Undisputed 01/23/2026 1084884421 CMS
Hologic Sales and Service, LLC $20.21 11/12/2024 Food and Beverage Undisputed 01/23/2026 1084884479 CMS
Organon Llc $20.23 02/12/2024 Food and Beverage Undisputed 01/23/2026 1136214309 CMS
PFIZER INC. $25.05 07/15/2024 Food and Beverage Undisputed 01/23/2026 1131620897 CMS
PFIZER INC. $19.68 09/04/2024 Food and Beverage Undisputed 01/23/2026 1131976243 CMS
PFIZER INC. $17.70 10/21/2024 Food and Beverage Undisputed 01/23/2026 1131962872 CMS
PFIZER INC. $19.92 12/05/2024 Food and Beverage Undisputed 01/23/2026 1131626248 CMS
Sage Therapeutics, Inc. $24.30 05/01/2024 Food and Beverage Undisputed 01/23/2026 1120405428 CMS
Sage Therapeutics, Inc. $15.65 05/09/2024 Food and Beverage Undisputed 01/23/2026 1120397855 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.